Сахарный диабет и все о нем!

Treating type 2 diabetes with liraglutide [human glucagon-like peptide-1 (GLP-1) analog] as an add-on to metformin and rosiglitazone improves beta cell function, and lowers blood glucose levels, blood pressure, and body weight, according to the results of a phase III clinical trial. The data from the Liraglutide Effect and Action in Diabetes (LEAD 4) study were presented at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) held in Rome, Italy, from September 7-11, 2008.